Analysis of approach to therapy for chronic liver disease in an HCV hyperendemic area of Japan

Hepatology Research

Volumn 28, Issue 1, 2004, Pages 30-35

  Nagao, Yumiko ^a   Tanaka, Kazuo ^a   Kobayashi, Kaoru ^b   Kumashiro, Ryukichi ^a   Sata, Michio ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Health and Welfare Section   (Japan)

Author keywords

Epidemiology; HCV carrier; Hepatitis C virus (HCV); Hepatocellular carcinoma (HCC); Hyperendemic area; Liver medical specialist

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT; GLYCYRRHIZIC ACID; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HEPATITIS C ANTIGEN; INTERFERON; RIBAVIRIN; URSODEOXYCHOLIC ACID; VIRUS RNA;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; ARTIFICIAL EMBOLISM; CATHETER ABLATION; CHRONIC LIVER DISEASE; CONSULTATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CARRIER; DRUG EFFICACY; DRUG RESPONSE; ECHOGRAPHY; ENDEMIC DISEASE; FEMALE; HEALTH CARE QUALITY; HEALTH PROGRAM; HEMOLYTIC ANEMIA; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; JAPAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PRIORITY JOURNAL; SEROLOGY; SURVIVAL; TERATOGENICITY;

EID: 0742306110     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2003.08.005     Document Type: Article

References (17)

1. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 1999;6:35-47.
2. Yoshizawa H. Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future Oncology 62Suppl. 1 2002 8-17
3. Higuchi M. Tanaka E. Kiyosawa K. Epidemiology and clinical aspects on hepatitis C Jpn. J. Infect. Dis. 55 2002 69-77
4. Ikeda K. Saitoh S. Koida I. et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis Hepatology 18 1993 47-53
5. Niederau C. Lange S. Heintges T. et al. Prognosis of chronic hepatitis C: results of a large, prospective cohort study Hepatology 28 1998 1687-1695
6. Sata M. Nakano H. Suzuki H. et al. Sero-epidemiologic study of hepatitis C virus infection in Fukuoka, Japan J. Gastroenterol. 33 1998 218-222
7. Fukuizumi K. Sata M. Suzuki H. Nakano H. Tanikawa K. Hepatitis C virus seroconversion rate in a hyperendemic area of HCV in Japan: a prospective study Scand. J. Infect. Dis. 29 1997 345-347
8. Fukuizumi K. Sata M. Suzuki H. Kumashiro R. Tanikawa K. Natural disappearance of serum HCV RNA prospective study in a hyperndemic area Hepatol. Res. 9 1997 144-151
9. Noguchi S. Sata M. Suzuki H. Mizokami M. Tanikawa K. Routes of transmission of hepatitis C virus in an endemic rural area of Japan. Molecular epidemiologic study of hepatitis C virus infection Scand. J. Infect. Dis. 29 1997 23-28
10. Nagao Y. Fukuizumi K. Tanaka K. Kumashiro R. Sata M. The prognosis for life in an HCV hyperendemic area Gastroenterology 125 2003 628-629
11. Nagao Y. Sata M. Fukuizumi K. Tanikawa K. Kameyama T. High incidence of oral precancerous lesions in a hyperendemic area of hepatitis C virus infection Hepatol. Res. 8 1997 173-177
12. Nagao Y. Sata M. Fukuizumi K. Ryu F. Ueno T. High incidence of oral lichen planus in an HCV hyperendemic area Gastroenterology 119 2000 882-883
13. Patrick L. Hepatitis C: epidemiology and review of complementary/alternative medicine treatments Altern. Med. Rev. 4 1999 220-238
14. McHutchinson J.G. Gordon S.C. Schiff E.R. et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C N. Eng. J. Med. 339 1998 1485-1492
15. Sherman A. HCV on the threshold Infect. Med. 16 1999 92-94
16. Fujisawa K, Tandon BN. Therapeutic approach to the chronic active liver disease: summary of a satellite symposium. In: Nishioka K, Suzuki H, Mishiro S, et al., editors. Viral hepatitis and liver disease. Tokyo: Springer; 1994. p. 662-5.
17. Arase Y. Ikeda K. Murashima N. The long term efficacy of glycyrrhizin in chronic hepatitis C patients Cancer 79 1997 1494-1500